Cardiovascular Actions and Clinical Outcomes with Glucagon-Like Peptide-1 Receptor Agonists and Dipeptidyl Peptidase-4 Inhibitors
Nauck MA, Meier JJ, Matthew A, et al.
Circulation 2017;136:849-70
Leggi
Nauck MA, Meier JJ, Matthew A, et al.
Circulation 2017;136:849-70
Leggi
Katikireddi SV, Skivington K, Leyland AH, et al.
BMC Medicine. Pub. online August 24, 2017
Leggi
Morici N, Savonitto S, Ponticelli C, et al.
Am J Med 2017;130(9):1068-75
Leggi
Papademetriou V, Nylen ES, Doumas M, et al.
Am J Med. Pub. online August 22, 2017
Leggi
D’Errico MM, Mangiacotti A, Graziano D, Massa V, Piscitelli P, Vendemiale G, Viazzi F, Pontremoli R, Russo E, Marchese N, Vigna C, De Cosmo S
Acta Diabetologica. Pub. online July 21, 2017
Leggi
Diaz KM, Goldsmith J, Greenlee H, et al.
Circulation Pub. online August 23, 2017
Leggi
Byrne JL, Davies MJ, Willaing I, et al.
Diabetic Medicine 2017;34(8):1074-83
Leggi
Fadini GP, Avogaro A
Lancet Diabetes Endocrinol 2017;5(9):680-1
Leggi
Kouidrat Y, Pizzol D, Cosco T, et al.
Diabetic Medicine. Pub. online 18 July 2017
Leggi
Odgers Jewell K, Ball L, Kelly JT, et al.
Diabetic Medicine 2017;34(8):1027.39
Leggi